Lung Cancer Trials Ask AI to find trials
TerminatedPhase 2NCT01103037
Official study title

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Study summary

This study will assess the safety and efficacy of QAV680 in patients with mild to moderate asthma

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedQAV680 and QAV680 Placebo

The study team can explain what participation involves.

Who it may be forAsthma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Dec 19, 2020 · Source: ClinicalTrials.gov

Is enrollment open?Terminated

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 2

Interventional

Where is it offered?7 U.S. locations

Locations may change over time.

Who runs it?Novartis Pharmaceuticals

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 2
Sponsor
Novartis Pharmaceuticals
Interventions being studied
Drug: QAV680; Drug: QAV680 Placebo
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patients with moderate persistent asthma

Reasons someone may not be able to joinExclusion criteria
  • Smokers
  • Any significant disease or illness, other than asthma Other protocol-defined inclusion/

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • West Coast Clinical TrialsCypress, California
  • American Health ResearchCharlotte, North Carolina
  • North Carolina Clinical ResearchRaleigh, North Carolina
  • Novartis Investigative SiteBerlin
  • Novartis Investigative SiteHamburg
  • Novartis Investigative SiteWiesbaden
  • Novartis Investigative SiteMoscow

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 19, 2020. Always confirm current availability with the study team.

View original record ↗